Equitable Holdings, Inc. Ligand Pharmaceuticals Inc Transaction History
Equitable Holdings, Inc.
- $10.1 Billion
- Q4 2024
A detailed history of Equitable Holdings, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Equitable Holdings, Inc. holds 3,714 shares of LGND stock, worth $408,354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,714
Previous 2,586
43.62%
Holding current value
$408,354
Previous $259,000
53.28%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LGND
# of Institutions
277Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$316 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$229 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$112 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$97.2 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$81.8 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.86B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...